SG Americas Securities
CABA icon

SG Americas Securities’s Cabaletta Bio CABA Stock Holding History

SG Americas Securities’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-30,629
Closed -$67K – 3268
2025
Q4 		$67K Buy
30,629
+9,365
+44% +$23.2K ﹤0.01% 3313
2025
Q3 		$50K Sell
21,264
-2,784
-12% -$4.78K ﹤0.01% 3202
2025
Q2 		$37K Sell
24,048
-12,228
-34% -$19.1K ﹤0.01% 2788
2025
Q1 		$50K Sell
36,276
-6,983
-16% -$14.9K ﹤0.01% 3244
2024
Q4 		$98K Buy
43,259
+8,161
+23% +$28.7K ﹤0.01% 2752
2024
Q3 		$166K Buy
+35,098
New +$203K ﹤0.01% 2633
2024
Q1 		– Sell
-9,740
Closed -$221K – 3008
2023
Q4 		$221K Buy
+9,740
New +$164K ﹤0.01% 2067
2022
Q1 		– Sell
-11,186
Closed -$42K – 3002
2021
Q4 		$42K Buy
+11,186
New +$119K ﹤0.01% 3212
2020
Q4 		– Sell
-12,275
Closed -$133K – 3341
2020
Q3 		$133K Sell
12,275
-10,579
-46% -$122K ﹤0.01% 2341
2020
Q2 		$255K Buy
+22,854
New +$175K ﹤0.01% 2645

Other funds holding CABA

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

SG Americas Securities's CABA Position: Q1 2026 in Review

SG Americas Securities sold out of Cabaletta Bio (CABA) in Q1 2026, closing a stake of 30,629 shares — an estimated $67K sold.

SG Americas Securities first reported a position in CABA in Q2 2020 and held it in 10 quarters. The position peaked at $255K in Q2 2020. 108 funds tracked by Wall St. Rank hold CABA as of Q1 2026.

  • SG Americas Securities reported no remaining Cabaletta Bio position as of Q1 2026 after selling out during the quarter.
  • SG Americas Securities sold 30,629 Cabaletta Bio shares in Q1 2026, an estimated $67K.
  • SG Americas Securities first reported a position in Cabaletta Bio in Q2 2020 and held it in 10 quarters.
  • SG Americas Securities's Cabaletta Bio position peaked at $255K in Q2 2020.
  • 108 funds tracked by Wall St. Rank held Cabaletta Bio as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.